552 related articles for article (PubMed ID: 31068134)
1. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism.
Beysel S; Caliskan M; Kizilgul M; Apaydin M; Kan S; Ozbek M; Cakal E
BMC Cardiovasc Disord; 2019 May; 19(1):106. PubMed ID: 31068134
[TBL] [Abstract][Full Text] [Related]
2. Comparative utility of preoperative imaging in normocalcemic versus hypercalcemic primary hyperparathyroidism.
Montgomery KB; Gillis A; Ramonell KM; Fazendin JM; Lindeman B; Chen H
Am J Surg; 2023 Feb; 225(2):293-297. PubMed ID: 36175194
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism.
Koumakis E; Souberbielle JC; Sarfati E; Meunier M; Maury E; Gallimard E; Borderie D; Kahan A; Cormier C
J Clin Endocrinol Metab; 2013 Aug; 98(8):3213-20. PubMed ID: 23783096
[TBL] [Abstract][Full Text] [Related]
4. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
Pierreux J; Bravenboer B
Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
[TBL] [Abstract][Full Text] [Related]
5. Twenty-four hour Holter ECG in normocalcemic and hypercalcemic patients with hyperparathyroidism.
Pepe J; Magna A; Sonato C; Sgreccia A; Colangelo L; Occhiuto M; Cilli M; Minisola S; Cipriani C
J Endocrinol Invest; 2024 Jun; 47(6):1499-1504. PubMed ID: 38141155
[TBL] [Abstract][Full Text] [Related]
6. Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism.
Koumakis E; Souberbielle JC; Payet J; Sarfati E; Borderie D; Kahan A; Cormier C
Osteoporos Int; 2014 Jul; 25(7):1963-8. PubMed ID: 24676846
[TBL] [Abstract][Full Text] [Related]
7. [Primary hyperparathyroidism - new clinical forms of the disease].
Zajíčková K
Vnitr Lek; 2017; 63(9):604-608. PubMed ID: 29120658
[TBL] [Abstract][Full Text] [Related]
8. Current opinions on nephrolithiasis associated with primary hyperparathyroidism.
Cong X; Shen L; Gu X
Urolithiasis; 2018 Oct; 46(5):453-457. PubMed ID: 29350243
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism.
Tordjman KM; Yaron M; Izkhakov E; Osher E; Shenkerman G; Marcus-Perlman Y; Stern N
Eur J Endocrinol; 2010 May; 162(5):925-33. PubMed ID: 20421337
[TBL] [Abstract][Full Text] [Related]
10. Patients with normocalcemic primary hyperparathyroidism may have similar metabolic profile as hypercalcemic patients.
Yener Ozturk F; Erol S; Canat MM; Karatas S; Kuzu I; Dogan Cakir S; Altuntas Y
Endocr J; 2016; 63(2):111-8. PubMed ID: 26581584
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism.
Sho S; Kuo EJ; Chen AC; Li N; Yeh MW; Livhits MJ
Ann Surg Oncol; 2019 Feb; 26(2):539-546. PubMed ID: 30406488
[TBL] [Abstract][Full Text] [Related]
12. Is parathyroidectomy safe and effective in patients with normocalcemic primary hyperparathyroidism?
Traini E; Bellantone R; Tempera SE; Russo S; De Crea C; Lombardi CP; Raffaelli M
Langenbecks Arch Surg; 2018 May; 403(3):317-323. PubMed ID: 29541851
[TBL] [Abstract][Full Text] [Related]
13. [Normocalcemic primary hyperparathyroidism].
Spivacow FR; Sapag Durán A; Zanchetta MB
Medicina (B Aires); 2014; 74(6):457-61. PubMed ID: 25555006
[TBL] [Abstract][Full Text] [Related]
14. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype.
Lowe H; McMahon DJ; Rubin MR; Bilezikian JP; Silverberg SJ
J Clin Endocrinol Metab; 2007 Aug; 92(8):3001-5. PubMed ID: 17536001
[TBL] [Abstract][Full Text] [Related]
15. Biochemical markers of endothelial activation in primary hyperparathyroidism.
Fallo F; Cella G; Casonato A; Ermani M; Vettor R; Zanella S; Lumachi F
Horm Metab Res; 2006 Feb; 38(2):125-9. PubMed ID: 16523414
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular manifestations of primary hyperparathyroidism: a narrative review.
Pepe J; Cipriani C; Sonato C; Raimo O; Biamonte F; Minisola S
Eur J Endocrinol; 2017 Dec; 177(6):R297-R308. PubMed ID: 28864535
[TBL] [Abstract][Full Text] [Related]
17. ECHOCARDIOGRAPHIC FINDINGS IN PATIENTS WITH NORMOCALCEMIC PRIMARY HYPERPARATHYROIDISM COMPARED WITH FINDINGS IN HYPERCALCEMIC PRIMARY HYPERPARATHYROID PATIENTS AND CONTROL SUBJECTS.
Pepe J; Colangelo L; Sonato C; Occhiuto M; Ferrara C; Del Fattore A; Santori R; Mastrantonio M; Sgreccia A; Minisola S; Cipriani C
Endocr Pract; 2021 Jan; 27(1):21-26. PubMed ID: 33475498
[TBL] [Abstract][Full Text] [Related]
18. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study.
Rejnmark L; Amstrup AK; Mollerup CL; Heickendorff L; Mosekilde L
J Clin Endocrinol Metab; 2013 Jan; 98(1):87-96. PubMed ID: 23150677
[TBL] [Abstract][Full Text] [Related]
19. Normocalcemic hyperparathyroidism: A Collaborative Endocrine Surgery Quality Improvement Program analysis.
Pandian TK; Lubitz CC; Bird SH; Kuo LE; Stephen AE
Surgery; 2020 Jan; 167(1):168-172. PubMed ID: 31543325
[TBL] [Abstract][Full Text] [Related]
20. Effects of successful parathyroidectomy on metabolic cardiovascular risk factors in patients with severe primary hyperparathyroidism.
Ishay A; Herer P; Luboshitzky R
Endocr Pract; 2011; 17(4):584-90. PubMed ID: 21324826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]